Bioavailability and Pharmacokinetics of TRPV1 Antagonist Mavatrep (JNJ‐39439335) Tablet and Capsule Formulations in Healthy Men: Two Open‐Label, Crossover, Single‐Dose Phase 1 Studies.

Autor: Manitpisitkul, Prasarn1, Shalayda, Kevin1 KShalayd@its.jnj.com, Russell, Lucille1, Sanga, Panna1, Williams, Yinka1, Solanki, Bhavna1, Caruso, Joseph1, Moyer, John A.1
Zdroj: Clinical Pharmacology in Drug Development. Sep2018, Vol. 7 Issue 7, p699-711. 13p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje